JAK3 and acute lymphoblastic leukemia: Thus, around one-quarter of T-ALL patients harboring JAK3 GOF mutations also possessed RUNX1 LOF mutations, with co-mutation enriched in the ETP-ALL cohort, while JAK3 GOF and RUNX LOF mutations synergized in a murine T-ALL model [61].